Literature DB >> 9788813

Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci.

B Beall1, R R Facklam, J A Elliott, A R Franklin, T Hoenes, D Jackson, L Laclaire, T Thompson, R Viswanathan.   

Abstract

The T-agglutination types were determined for a diverse collection of 1531 group A streptococci for which the 5' M protein gene (emm) sequences had been analysed. The majority of the T-agglutination types correlated with previously seen M/emm/T-type associations; however, several new associations were found. Analysis of a subset of this collection -- which included 1157 clinical isolates with multiply encountered emm types -- found that emm amplicon restriction profiles of isolates sharing identical T types and opacity factor phenotypes are useful for detecting groups of isolates with identical emm genes. Many emm genes of known 5' sequence display a highly conserved restriction pattern amongst clinical isolates widely separated both geographically and temporally.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788813     DOI: 10.1099/00222615-47-10-893

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

1.  Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden.

Authors:  A Jasir; A Tanna; A Efstratiou; C Schalén
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  emm typing of M nontypeable invasive group A streptococcal isolates in Israel.

Authors:  Allon E Moses; Carlos Hidalgo-Grass; Mary Dan-Goor; Joseph Jaffe; Ilanit Shetzigovsky; Miriam Ravins; Zinaida Korenman; Ronit Cohen-Poradosu; Ran Nir-Paz
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002.

Authors:  Jing-Jou Yan; Ching-Chuan Liu; Wen-Chien Ko; Shui-Yuan Hsu; Hsiu-Mei Wu; Yee-Shin Lin; Ming T Lin; Woei-Jer Chuang; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

4.  Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.

Authors:  C Silva-Costa; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy.

Authors:  G Dicuonzo; G Gherardi; G Lorino; S Angeletti; M De Cesaris; E Fiscarelli; D E Bessen; B Beall
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.

Authors:  M D Pinho; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Invasive group A streptococcal disease: Management and chemoprophylaxis.

Authors:  Ud Allen; Dl Moore
Journal:  Paediatr Child Health       Date:  2010-05       Impact factor: 2.253

8.  Invasive group A streptococcal disease: Management and chemoprophylaxis.

Authors:  Ud Allen; Dl Moore
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

9.  Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption.

Authors:  C Silva-Costa; A Friães; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

10.  Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure.

Authors:  Rebecca J Towers; Peter K Fagan; Susanne R Talay; Bart J Currie; Kadaba S Sriprakash; Mark J Walker; Gursharan S Chhatwal
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.